Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a descriptive genomic characterization study of UPEC isolates without clinical outcomes, experimental validation, or comparator groups; it reports pangenome structure and resistance/virulence gene profiles but does not test an intervention or establish causation.
First descriptive report of HCV genome sequencing and resistance patterns in an Indian cohort; uncontrolled, hospital-based study with small sample and no comparator arm, useful for surveillance but insufficient to guide treatment decisions.
Single-isolate laboratory study characterizing a novel phage and resistance mechanisms with in vitro and insect model validation, but lacking human clinical data or comparative efficacy trials.
A single-centre diagnostic accuracy study of moderate size with sound methodology but surrogate endpoints (categorical agreement, MIC prediction) rather than clinical outcomes, showing the NMIC-150 system performs comparably to reference broth microdilution for ESBL detection.
Large retrospective genomic-epidemiological analysis of 554 confirmed cases with whole-genome sequencing confirms known risk factors for melioidosis mortality and antimicrobial susceptibility patterns, with novel phylogeographic clustering data.